Abstract:Matrix metalloproteinases (MMPs) have been implicated to play a critical role in glioma invasiveness. In this study, we aimed to investigate, the expression of MMP-2 and MMP-9 in human gliomas of different degrees of malignancy, and evaluated the correlation between MMP-2 and MMP-9 expression in gliomas. The samples from 65 cases of glioma were divided into four groups according to the WHO classification: there were 16 cases of grade I, 17 cases of grade II, 20 cases of grade III, and 12 cases of grade IV. Normal brain samples served as the control group, and biopsy specimens were obtained from 8 glioma patients with a needle placed into the adjacent brain 1 cm from the margin after tumor resection. All the samples were stained with hematoxylin and eosin and immunohistochemistry. A computer-aided image-analysis system was employed to measure the integral optical density (IOD) of positive slides. No positive staining was found in the control group. The positive staining was localized in the cytoplasm of glioma cells, the extracellular matrix (ECM), the basement membrane (BM), and the endothelial cells of blood vessels. Positive staining rates increased significantly when the degree of malignancy of gliomas was elevated. The IOD value of MMP-2 and MMP-9 also indicated that the intensity of MMP-2 and MMP-9 expression was elevated significantly with the degree of malignancy of the gliomas. There was a positive correlation between MMP-2 and MMP-9 expression in gliomas. Glioma invasion and angiogenesis were particularly seen in the biopsied tissues, and MMP-9 immunostaining seemed to be much more intense and extensive than MMP-2 immunostaining in these samples. These results suggest that MMP-2 and MMP-9 staining in gliomas is localized in the cytoplasm of tumor cells, BM, and endothelial cells, and that MMP-2 and MMP-9 together play an important role in the invasiveness of gliomas, mediating the degradation of the ECM and angiogenesis. MMP-2 and MMP-9 could be molecular targets in the treatment of malignant glioma.

Relationship Between Expression of Matrix Metalloproteinase-2, Matrix Metalloproteinase-9 Mrna and Angiogenesis in Astrocytomas

Expression and Significance of Matrix Matalloproteinase and Tissue Inhibitor of Metalloproteinase in Human Astrocytomas

Expression of Enos and VEGF in Association with Angiogenesis of Human Astrocytoma

Expression of Endothelial Nitric Oxide Synthase and Vascular Endothelial Growth Factor in Association with Neovascularization in Human Primary Astrocytoma.

The Expression of Vascular Endothelial Growth Factor, Matrix Metalloproteinases 2,9 in Osteosarcoma

Relationship between the expression of matrix metalloproteinase-9 and angiogenesis in glioma and its clinical significance

Correlation between the expression of matrix metalloproteinase-9 and angiogenesis in glioma and its significance for prevention and cure of tumor

Expression of Matrix Metalloproteinase-9 and Their Correlation with Tumor Invasion, Metastasis in Gastric Carcinoma

Expression and significance of vascuIar endothelial growth factor and Ⅷ-R Ag in human brain glioma

Expression and significance of vascuIar endothelial growth factor and VIII-R Ag in human brain glioma

Expression and Biologic Significance of Vascular Endothelial Growth Factor (VEGF) in Human Meningiomas

The Expression of CD44s and Mib-1 in Astrocytomas and Their Clinical Significance

Expression of high mobility group A2 and matrix metalloproteinase 2 and their correlation with malignancy and invasion in astrocyte tumors

Relationship between microvascular density,expression of matrix metalloproteinase-9 and clinical pathology in glioma

The relationship of expression of matrix metalloproteinase 2 in blood serum and prognostic of astrocytoma

Relationship between MMP-9 and angiogenesis in renal cell cacinoma

The expression of matrix metalloproteinase-2 and-9 in human gliomas of different pathological grades

EXPRESSION OF MATRIX METALLOPROTEINASE-2 AND VASCULAR ENDOTHELIAL GROWTH FACTOR IN HUMAN GLIOMA AND THEIR RELATION TO THE INVASION OF THE TUMOR

Relationship between matrix metalloproteinase-2 mRNA expression and clinicopathological and urokinase-type plasminogen activator system parameters and prognosis in human gastric cancer

The expressions of VEGF and COX- 2 protein in astrocytoma

Relationship Between Matrix Metalloproteinase-9 Expression and MRI Characteristics of Glioma